Mepolizumab in the Treatment of Severe Eosinophilic Asthma
- 10 December 2015
- journal article
- review article
- Published by Taylor & Francis in Immunotherapy
- Vol. 8 (1) , 27-34
Abstract
IL-5 is crucial in the pathogenesis and evolution of eosinophilic asthma. Mepolizumab is a high-affinity humanized monoclonal antibody of the IgG1/k subtype that inhibits the binding of IL-5 to its receptor expressed on eosinophils, thereby inducing significant reduction in eosinophil circulation, as well as asthma exacerbations and corticosteroid treatment. This review deals with the currently available studies of mepolizumab in the treatment of patients with severe eosinophilic asthma.Keywords
This publication has 39 references indexed in Scilit:
- Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled TrialsPLOS ONE, 2013
- Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal AntibodyClinical Pharmacokinetics, 2011
- Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levelsJournal of Allergy and Clinical Immunology, 2008
- Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research ProgramJournal of Allergy and Clinical Immunology, 2007
- THE EOSINOPHILAnnual Review of Immunology, 2006
- Inflammatory subtypes in asthma: Assessment and identification using induced sputumRespirology, 2006
- Intravenous Anti-IL-5 Monoclonal Antibody Reduces Eosinophils and Tenascin Deposition in Allergen-Challenged Human Atopic SkinJournal of Investigative Dermatology, 2004
- Therapeutic efficacy of an anti–IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthmaJournal of Allergy and Clinical Immunology, 1999
- Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthmaJournal of Allergy and Clinical Immunology, 1993
- Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.Journal of Clinical Investigation, 1991